Bowflex (BFXXQ) 10-Q 14 Nov 23 2024 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Sep. 30, 2023	Nov. 10, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-31321
Entity Registrant Name	BOWFLEX INC.
Entity Incorporation, State or Country Code	WA
Entity Tax Identification Number	94-3002667
Entity Address, Address Line One	17750 S.E. 6th Way
Entity Address, City or Town	Vancouver
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	98683
City Area Code	360
Local Phone Number	859-2900
Entity Information, Former Legal or Registered Name	Nautilus, Inc.
Title of 12(b) Security	Common Stock, no par value
Trading Symbol	BFX
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		36,361,526
Entity Central Index Key	0001078207
Current Fiscal Year End Date	--03-31
Amendment Flag	false
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Mar. 31, 2023
Current assets:
Cash and cash equivalents	$ 8,134	$ 17,362
Restricted cash	2,158	950
Trade receivables, net of allowances of $255 and $618	24,187	21,489
Inventories	66,077	46,599
Prepaids and other current assets	9,779	8,033
Income taxes receivable	7,215	1,789
Total current assets	117,550	96,222
Property, plant and equipment, net	28,352	32,789
Operating lease right-of-use assets	16,906	19,078
Other intangible assets, net	3,059	6,787
Deferred income tax assets, non-current	540	554
Income taxes receivable, non-current	0	5,673
Other assets	1,271	2,429
Total assets	167,678	163,532
Liabilities and Shareholders' Equity
Trade payables	63,235	29,378
Accrued liabilities	11,858	15,575
Operating lease liabilities, current portion	4,575	4,427
Finance lease obligations, current portion	123	122
Warranty obligations, current portion	2,560	2,564
Income taxes payable, current portion	1,089	328
Debt payable, current portion, net of unamortized debt issuance costs of $447 and $586	1,803	1,642
Total current liabilities	85,243	54,036
Operating lease liabilities, non-current	13,950	16,380
Finance lease obligations, non-current	225	282
Warranty obligations, non-current	859	703
Income taxes payable, non-current	2,055	2,316
Deferred income tax liabilities, non-current	128	253
Other non-current liabilities	4,108	1,978
Debt payable, non-current, net of unamortized debt issuance costs of $931 and $1,513	13,987	26,284
Total liabilities	120,555	102,232
Commitments and contingencies (Note 19)
Shareholders' equity:
Common stock - no par value, 75,000 shares authorized, 36,347 and 31,845 shares issued and outstanding	13,612	10,084
Retained earnings	35,227	52,694
Accumulated other comprehensive loss	(1,716)	(1,478)
Total shareholders' equity	47,123	61,300
Total liabilities and shareholders' equity	$ 167,678	$ 163,532

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) shares in Thousands, $ in Thousands	Sep. 30, 2023	Mar. 31, 2023
Statement of Financial Position [Abstract]
Allowance for doubtful trade receivables	$ 255	$ 618
Debt Issuance Costs, Current, Net	447	586
Debt Issuance Costs, Noncurrent, Net	$ 931	$ 1,513
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized	75,000	75,000
Common stock, shares issued	36,347	31,845
Common stock, shares outstanding	36,347	31,845

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net sales	$ 48,659	$ 65,458	$ 90,409	$ 120,275
Cost of sales	38,705	54,000	71,805	101,859
Gross profit	9,954	11,458	18,604	18,416
Operating expenses:
Selling and marketing	7,023	9,400	13,024	22,290
General and administrative	8,980	10,995	17,874	23,458
Research and development	3,836	5,405	7,684	11,229
Restructuring and exit charges	1,323	0	1,763	0
Goodwill and intangible impairment charge	0	0	0	26,965
Total operating expenses	21,162	25,800	40,345	83,942
Operating loss	(11,208)	(14,342)	(21,741)	(65,526)
Other expense:
Interest income	3	4	17	5
Interest expense	(1,137)	(595)	(3,604)	(971)
Other, net	251	(224)	8,818	(739)
Total other expense, net	(883)	(815)	5,231	(1,705)
Loss from continuing operations before income taxes	(12,091)	(15,157)	(16,510)	(67,231)
Income tax expense	452	156	957	8,251
Loss from continuing operations	(12,543)	(15,313)	(17,467)	(75,482)
Discontinued operations:
Loss from discontinued operations before income taxes	0	(32)	0	(32)
Income tax benefit of discontinued operations	0	(2,142)	0	(2,134)
Income from discontinued operations	0	2,110	0	2,102
Net loss	$ (12,543)	$ (13,203)	$ (17,467)	$ (73,380)
Earnings Per Share, Basic [Abstract]
Basic income (loss) per share from continuing operations (in dollars per share)	$ (0.35)	$ (0.48)	$ (0.51)	$ (2.40)
Basic loss per share from discontinued operation (in dollars per share)	0	0.07	0	0.07
Basic net income (loss) per share (in dollars per share)	(0.35)	(0.41)	(0.51)	(2.33)
Earnings Per Share, Diluted [Abstract]
Diluted income (loss) per share from continuing operations (in dollars per share)	(0.35)	(0.48)	(0.51)	(2.40)
Diluted loss per share from discontinued operation (in dollars per share)	0	0.07	0	0.07
Diluted net income (loss) per share (in dollars per share)	$ (0.35)	$ (0.41)	$ (0.51)	$ (2.33)
Shares used in per share calculations:
Basic (in shares)	36,008	31,585	34,192	31,496
Diluted (in shares)	36,008	31,585	34,192	31,496

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (12,543)	$ (13,203)	$ (17,467)	$ (73,380)
Other comprehensive loss:
Foreign currency translation, net of income tax expense of $(15), $(56), $(7), and $(85)	(416)	(1,221)	(238)	(2,080)
Comprehensive loss	$ (12,959)	$ (14,424)	$ (17,705)	$ (75,460)

Condensed Condensed Consolidate

Condensed Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parentheticals) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2021	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Foreign currency translation tax expense (benefit)	$ (15)	$ 8	$ (56)	$ (29)	$ (7)	$ (85)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Additional Paid-in Capital
Beginning balance at Mar. 31, 2022	$ 164,049	$ 6,483	$ 158,093	$ (527)
Balance, shares at Mar. 31, 2022		31,268
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(60,177)		(60,177)
Foreign currency translation adjustment, including income tax expense (benefit)	(859)			(859)
Stock-based compensation expense	1,979	$ 1,979
Common stock issued under equity compensation plan, net of shares withheld for tax payments (in shares)		205
Common stock issued under equity compensation plan, net of shares withheld for tax payments	(270)	$ (270)
Common stock issued under employee stock purchase plan, shares		0
Common stock issued under employee stock purchase plan	125	$ 125
Balance, shares at Jun. 30, 2022		31,473
Ending balance at Jun. 30, 2022	104,847	$ 8,317	97,916	(1,386)
Beginning balance at Mar. 31, 2022	164,049	$ 6,483	158,093	(527)
Balance, shares at Mar. 31, 2022		31,268
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(73,380)
Foreign currency translation adjustment, including income tax expense (benefit)	(2,080)
Balance, shares at Sep. 30, 2022		31,714
Ending balance at Sep. 30, 2022	91,619	$ 9,513	84,713	(2,607)
Beginning balance at Jun. 30, 2022	104,847	$ 8,317	97,916	(1,386)
Balance, shares at Jun. 30, 2022		31,473
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(13,203)		(13,203)
Foreign currency translation adjustment, including income tax expense (benefit)	(1,221)			(1,221)
Stock-based compensation expense	1,367	$ 1,367
Common stock issued under equity compensation plan, net of shares withheld for tax payments (in shares)		241
Common stock issued under equity compensation plan, net of shares withheld for tax payments	(171)	$ (171)
Balance, shares at Sep. 30, 2022		31,714
Ending balance at Sep. 30, 2022	91,619	$ 9,513	84,713	(2,607)
Beginning balance at Mar. 31, 2023	61,300	$ 10,084	52,694	(1,478)	$ 0
Balance, shares at Mar. 31, 2023		31,845
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(4,924)		(4,924)
Foreign currency translation adjustment, including income tax expense (benefit)	178			178
Issuance of common stock and pre-funded warrants, net (in shares)		3,525
Issuance of common stock and pre-funded warrants, net	1,552	$ 1,335			217
Stock-based compensation expense (in shares)		34
Stock-based compensation expense	1,050	$ 1,050
Common stock issued under equity compensation plan, net of shares withheld for tax payments (in shares)		(69)
Common stock issued under equity compensation plan, net of shares withheld for tax payments	(85)	$ (85)
Common stock issued under employee stock purchase plan, shares		180
Common stock issued under employee stock purchase plan	0	$ 0
Balance, shares at Jun. 30, 2023		35,515
Ending balance at Jun. 30, 2023	59,071	$ 12,384	47,770	(1,300)	217
Beginning balance at Mar. 31, 2023	61,300	$ 10,084	52,694	(1,478)	0
Balance, shares at Mar. 31, 2023		31,845
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(17,467)
Foreign currency translation adjustment, including income tax expense (benefit)	(238)
Balance, shares at Sep. 30, 2023		36,347
Ending balance at Sep. 30, 2023	47,123	$ 13,612	35,227	(1,716)
Beginning balance at Jun. 30, 2023	59,071	$ 12,384	47,770	(1,300)	217
Balance, shares at Jun. 30, 2023		35,515
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(12,543)		(12,543)
Foreign currency translation adjustment, including income tax expense (benefit)	(416)			(416)
Issuance of common stock and pre-funded warrants, net (in shares)		573
Issuance of common stock and pre-funded warrants, net	119	$ 336			$ (217)
Stock-based compensation expense	926	926
Common stock issued under equity compensation plan, net of shares withheld for tax payments		$ (34)
Common stock issued under equity compensation plan, shares		(58)
Common stock issued under employee stock purchase plan, shares		317
Common stock issued under employee stock purchase plan	0	$ 0
Balance, shares at Sep. 30, 2023		36,347
Ending balance at Sep. 30, 2023	$ 47,123	$ 13,612	$ 35,227	$ (1,716)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders' Equity - Parenthetical (Unaudited) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2021	Sep. 30, 2023	Sep. 30, 2022
Statement of Stockholders' Equity [Abstract]
Foreign currency translation tax expense (benefit)	$ 15	$ (8)	$ 56	$ 29	$ 7	$ 85

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Mar. 31, 2022	Mar. 31, 2023
Cash flows from operating activities:
Loss from continuing operations	$ (12,543)		$ (15,313)		$ (17,467)	$ (75,482)
Income from discontinued operations	0		2,110		0	2,102
Net loss	(12,543)	$ (4,924)	(13,203)	$ (60,177)	(17,467)	(73,380)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization					6,256	4,786
Provision for allowance for doubtful accounts					88	585
Inventory lower-of-cost-or net realizable value adjustments					0	1,832
Stock-based compensation expense					1,941	3,346
Liability classified stock-based compensation expense					4	0
Gain on asset dispositions					(9,021)	0
Loss on debt extinguishment					352	0
Deferred income taxes, net of valuation allowances					114	8,167
Goodwill and intangible impairment charge	0		0		0	26,965
Other					138	(1,276)
Changes in operating assets and liabilities:
Trade receivables					(2,416)	28,363
Inventories					(18,553)	13,299
Prepaids and other assets					1,560	7,164
Income taxes receivable					247	354
Trade payables					34,757	(13,731)
Accrued liabilities and other liabilities, including warranty obligations					(5,931)	(16,070)
Net cash used in operating activities					(7,931)	(9,596)
Cash flows from investing activities:
Proceeds from Sale of Equity Method Investments					2,350	0
Proceeds from sale of indefinite-lived intellectual property	10,500				10,500	0
Purchases of property, plant and equipment					(1,902)	(7,511)
Net cash provided by (used in) investing activities					10,948	(7,511)
Cash flows from financing activities:
Proceeds from long-term debt					3,000	36,280
Payments on long-term debt					(15,976)	(19,399)
Payment of debt issuance costs					(918)	0
Early termination of debt					(353)	0
Payments on finance lease liabilities					(60)	(60)	$ (119)
Proceeds from public offering net of transaction costs					4,547	0
Proceeds from employee stock purchases					35	125
Tax payments related to stock award issuances					(119)	(430)
Net cash (used in) provided by financing activities					(9,844)	16,516
Effect of exchange rate changes					(1,193)	(6,869)
Net decrease in cash, cash equivalents and restricted cash					(8,020)	(7,460)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash at beginning of period		$ 18,312		$ 18,098	18,312	18,098
Cash, cash equivalents and restricted cash at end of period	10,292		10,638		10,292	10,638	18,098
Supplemental disclosure of cash flow information:
Cash paid for interest					1,327	770
Cash paid (received) for income taxes, net					104	(47)
Supplemental disclosure of non-cash investing activities:
Capital expenditures incurred but not yet paid					231	787
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same amounts shown above:
Cash and cash equivalents	8,134		5,805		8,134	5,805		$ 17,362
Restricted cash	2,158		946		2,158	946		950
Other current assets - restricted, current	0		3,887		0	3,887
Total cash, cash equivalents and restricted cash	$ 10,292		$ 10,638		$ 10,292	$ 10,638	$ 18,098	$ 18,312

General Information

General Information	6 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
General Information	GENERAL INFORMATION Basis of Consolidation and Presentation The accompanying condensed consolidated financial statements present the financial position, results of operations and cash flows of BowFlex Inc. and its subsidiaries, all of which are wholly owned. Intercompany transactions and balances have been eliminated in consolidation. The accompanying condensed consolidated financial statements have not been audited. We have condensed or omitted certain information and footnote disclosures normally included in financial statements presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes the disclosures contained herein are adequate to make the information presented not misleading. However, these condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2023 (the “2023 Form 10-K”) and for the 10-Q report for the period ended June 30, 2023. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Uncertainties regarding such estimates and assumptions are inherent in the preparation of financial statements and actual results could differ from those estimates. Further information regarding significant estimates can be found in our 2023 Form 10-K. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments necessary to present fairly our financial position as of September 30, 2023 and March 31, 2023, and our results of operations, comprehensive loss and shareholders' equity for the three and six-month periods ended September 30, 2023 and 2022 and our cash flows for the six-month periods ended September 30, 2023 and 2022. Interim results are not necessarily indicative of results for a full year. Our revenues typically vary seasonally, and this seasonality can have a significant effect on operating results, inventory levels and working capital needs. Unless indicated otherwise, all information regarding our operating results pertain to our continuing operations. Recent Accounting Pronouncements Recently Adopted Pronouncements ASU 2016-13 In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 requires companies to measure credit losses utilizing a methodology that reflects expected credit losses and requires a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. In May 2019, the FASB issued ASU 2019-05, which provides entities to have certain instruments with an option to irrevocably elect the fair value option. In November 2019, the FASB issued ASU 2019-11, which provides clarification and addresses specific issues about certain aspects of ASU 2016-13. In March 2020, the FASB issued ASC 2020-03, which provides an update to clarify or address specific issues. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those years. We adopted ASU 2016-13 on April 1, 2023 and it had no material impact on our financial position, results of operations or cash flows. ASU 2020-06 In August 2020, the FASB issued ASU No. 2020-06, "Debt—Debt with Conversion and Other Options (Subtopic 470-20)" and "Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity," which address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. ASU No. 2020-06 will become effective for us on January 1, 2024. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. FASB specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. We early adopted ASU No. 2020-06 on April 1, 2023 and it had no material impact on our financial position, results of operations or cash flows.

Discontinued Operations

Discontinued Operations	6 Months Ended
	Sep. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	DISCONTINUED OPERATIONSResults from discontinued operations relate to the disposal of our former Commercial business, which was completed in April 2011. Although we reached substantial completion of asset liquidation at December 31, 2012, we continued to accrue interest associated with an uncertain tax position on discontinued international operations, and incurred an immaterial amount of product liability expenses associated with products previously sold into the Commercial channel through fiscal 2023. Expenses related to discontinued operations were immaterial for the first six months of fiscal 2024.

Restructuring and Exit Charges

Restructuring and Exit Charges	6 Months Ended
	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring and Exit Charges	RESTRUCTURING AND EXIT CHARGES In February 2023, we announced and began implementing a restructuring plan that included a reduction in workforce and other exit costs. The following table summarizes restructuring reserve activity (in thousands): Employee Severance and Benefits Third Party Costs Total Accrued liability as of March 31, 2023 $ 1,110 $ 123 $ 1,233 Charges / Accruals — 1,763 1,763 Payments (753) (1,129) (1,882) Accrued liability as of September 30, 2023 $ 357 $ 757 $ 1,114

Revenues

Revenues	6 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenues	REVENUES Our revenues from contracts with customers disaggregated by revenue source, excluding sales-based taxes, were as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Product sales $ 44,424 $ 60,107 $ 81,196 $ 109,703 Extended warranties and services 776 938 1,526 1,980 Royalty income 143 1,072 570 1,950 Other (1) 3,316 3,341 7,117 6,642 Net sales $ 48,659 $ 65,458 $ 90,409 $ 120,275 (1) Other revenue is primarily subscription revenue and freight and delivery. Subscriptions Sales of our subscriptions are deemed to be one performance obligation and we recognize revenue from these arrangements ratably over the subscription term as the performance obligation is satisfied. Revenue generated from subscriptions is recorded in our Direct segment. We also offer free trials of subscriptions that are bundled with product offerings (e.g., subscription for premium content). For these types of transactions that involve multiple performance obligations, the transaction price requires allocations to the distinct performance obligation because the free trial provides a material right. The transaction price is then allocated to each performance obligation based on stand-alone selling price. We determine stand-alone selling price based on prices charged to customers. Breakage is factored into the determination of the stand-alone selling price of a subscription. Breakage or activation rate is defined as a percentage of those purchasers that never activate a free-trial offering. Our revenues disaggregated by geographic region, based on ship-to address, were as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 United States $ 38,787 $ 53,440 $ 71,007 $ 99,521 Canada 4,918 8,388 9,366 14,195 Europe, the Middle East and Africa 4,308 2,340 8,664 4,179 All other 646 1,290 1,372 2,380 Net sales $ 48,659 $ 65,458 $ 90,409 $ 120,275 The following table provides information about our liabilities from contracts with customers, primarily customer deposits and deferred revenue for which advance consideration is received prior to the transfer of control or the performance obligation is not satisfied. Revenue is recognized when transfer of control occurs. All customer deposits and deferred revenue received are short-term in nature, recognized over the next twelve months. Significant changes in contract liabilities balances, including revenue recognized in the reporting period that was included in opening contract liabilities, are shown below (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Balance, beginning of period $ 4,432 $ 6,582 $ 5,075 $ 6,285 Cash changes (239) (973) 148 576 Deferred Revenue 551 1,238 1,529 2,220 Revenue recognition (1,736) (2,654) (3,744) (4,888) Balance, end of period $ 3,008 $ 4,193 $ 3,008 $ 4,193

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	FAIR VALUE MEASUREMENTS Factors used in determining the fair value of financial assets and liabilities are summarized into three broad categories: • Level 1 - observable inputs such as quoted prices (unadjusted) in active liquid markets for identical securities as of the reporting date; • Level 2 - other significant directly or indirectly observable inputs, including quoted prices for similar securities, interest rates, prepayment speeds and credit risk, or observable market prices in markets with insufficient volume and/or infrequent transactions; and • Level 3 - significant inputs that are generally unobservable inputs for which there is little or no market data available, including our own assumptions in determining fair value. We did not have any assets measured at fair value on a recurring basis as of September 30, 2023, or March 31, 2023. Liabilities measured at fair value on a recurring basis were as follows (in thousands): September 30, 2023 Level 1 Level 2 Level 3 Total Liabilities: Common Warrants $ — $ — $ 1,618 $ 1,618 Derivatives Foreign currency forward contracts — 20 — 20 Total liabilities measured at fair value $ — $ 20 $ 1,618 $ 1,638 March 31, 2023 Level 1 Level 2 Level 3 Total Liabilities: Derivatives Foreign currency forward contracts $ — $ 141 $ — $ 141 Total liabilities measured at fair value $ — $ 141 $ — $ 141 We did not have any changes to our valuation techniques during any periods presented. The fair value of our foreign currency forward contracts is calculated as the present value of estimated future cash flows using discount factors derived from relevant Level 2 market inputs, including forward curves and volatility levels. The carrying value of our debt approximates its fair value and falls under Level 2 of the fair value hierarchy, as the interest rate is variable and based on current market rates. We determined the fair value of the Common Warrants (see Note 12) liability using the Black Scholes Option Pricing methodology with Level 3 inputs. Inherent in a Black Scholes valuation model are assumptions related to expected stock price, exercise price, stock-price volatility derived using our historical volatility, expected term, risk-free interest rate and dividend yield. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected term of the Common Warrants. The dividend yield percentage is zero based on our current expectations related to the payment of dividends during the expected term of the Common Warrants. The key inputs into the Black Scholes pricing model were as follows: September 30, 2023 Stock Price $0.85 Exercise Price $1.35 Expected Life 5.22 Expected Volatility 61.66% Expected Dividend Yield —% Risk Free Rate 4.55%

Derivatives

Derivatives	6 Months Ended
	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	DERIVATIVES From time to time, we enter into interest rate swaps to fix a portion of our interest expense, and foreign exchange forward contracts to offset the earnings impacts of exchange rate fluctuations on certain monetary assets and liabilities. We do not enter into derivative instruments for any purpose other than to manage interest rate or foreign currency exposure. That is, we do not engage in interest rate or currency exchange rate speculation using derivative instruments. We may hedge our net recognized foreign currency assets and liabilities with forward foreign exchange contracts to reduce the risk that our earnings and cash flows will be adversely affected by changes in foreign currency exchange rates. These derivative instruments hedge assets and liabilities that are denominated in foreign currencies and are carried at fair value with changes in the fair value recorded as other income. These derivative instruments do not subject us to material balance sheet risk due to exchange rate movements because gains and losses on these derivatives are intended to offset gains and losses on the assets and liabilities being hedged. As of September 30, 2023, total outstanding contract notional amounts were $2.3 million and had maturities of 62 days or less. The fair value of our derivative instruments was included in our Condensed Consolidated Balance Sheets as follows (in thousands): Balance Sheet Classification As of September 30, 2023 March 31, 2023 Derivative instruments not designated as cash flow hedges: Foreign currency forward contracts Accrued liabilities $ 20 $ 141 The effect of derivative instruments on our Condensed Consolidated Statements of Operations was as follows (in thousands): Statement of Operations Classification Three-Months ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Derivative instruments not designated as cash flow hedges: Income (loss) recognized in earnings Other, net $ 158 $ (685) $ 158 $ (589) Income tax expense (benefit) Income tax expense (benefit) 39 (170) 39 (146)

Inventories

Inventories	6 Months Ended
	Sep. 30, 2023
Inventory Disclosure [Abstract]
Inventories	INVENTORIESInventories are stated at the lower of cost and net realizable value, with cost determined based on the first-in, first-out method. Our inventories consisted of the following (in thousands): As of September 30, 2023 March 31, 2023 Finished goods $ 62,260 $ 42,463 Parts and components 3,817 4,136 Total inventories $ 66,077 $ 46,599

Property, Plant and Equipment

Property, Plant and Equipment	6 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	PROPERTY, PLANT AND EQUIPMENT Property, plant and equipment consisted of the following (in thousands): Estimated As of September 30, 2023 March 31, 2023 Automobiles 5 $ 23 $ 23 Leasehold improvements 4 to 20 3,446 3,426 Computer software and equipment 2 to 7 57,211 57,223 Machinery and equipment 3 to 5 15,188 14,953 Furniture and fixtures 5 to 20 2,033 2,034 Work in progress (1) N/A 5,604 4,061 Total cost 83,505 81,720 Accumulated depreciation (55,153) (48,931) Total property, plant and equipment, net $ 28,352 $ 32,789 (1) Work in progress includes information technology assets and production tooling. Depreciation expense was as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Depreciation expense $ 3,091 $ 2,464 $ 6,225 $ 4,755

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	6 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	OTHER INTANGIBLE ASSETS Other Intangible Assets Other intangible assets consisted of the following (in thousands): Estimated As of September 30, 2023 March 31, 2023 Indefinite-lived trademarks N/A $ 2,900 $ 6,597 Patents 7 to 24 1,043 1,043 3,943 7,640 Accumulated amortization - definite-lived intangible assets (884) (853) Other intangible assets, net $ 3,059 $ 6,787 During the quarter ended June 30, 2023, we completed the sale of indefinite-lived intellectual property for $10.5 million as part of our ongoing comprehensive strategic review. The sale of these assets, which included the Nautilus ® brand trademark assets and related licenses, will continue to streamline our brand focus and enhance our financial flexibility. The carrying value of the intangible assets sold was $3.7 million and the resulting gain, net of transaction costs, was recorded the Consolidated Statement of Operations as Other, net. Amortization expense was as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Amortization expense $ 15 $ 16 $ 31 $ 31 Future amortization of definite-lived intangible assets is as follows (in thousands): Remainder of fiscal 2024 $ 30 2025 61 2026 47 2027 3 2028 3 Thereafter 15 $ 159

The Sale of Shares In Equity In

The Sale of Shares In Equity Investments	6 Months Ended
	Sep. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]
The Sale of Shares In Equity Investments	THE SALE OF SHARES IN EQUITY INVESTMENTSOn May 1, 2023, we completed the sale of Vi Labs for $2.3 million as part of our ongoing comprehensive strategic review. The sale of this equity investment will continue to streamline our brand focus and enhance our financial flexibility. The carrying value of the assets sold was $0.0 million and transaction costs of the sale were $0.1 million. The resulting gain of $2.2 million was recorded in the Condensed Consolidated Statements of Operations as Other, net and in the Condensed Consolidated Statements of Cash Flows as Proceeds from sale of equity investment for the quarter ended June 30, 2023.

Leases

Leases	6 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Leases	LEASES We have several non-cancellable operating leases, primarily for office space, that expire at various dates over the next seven years. These leases generally contain renewal options to extend for one lease term of five years. For leases that we are reasonably certain we will exercise the lease renewal options, the options were considered in determining the lease term, and associated potential option payments are included in the lease payments. The payments used in the renewal term were estimated using the percentage rate increase of historical rent payments for each location where the renewal will be exercised. Payments due under the lease contracts include annual fixed payments for office space. Variable payments including payments for our proportionate share of the building’s property taxes, insurance, and common area maintenance are treated as non-lease components and are recognized in the period for which the costs occur. Lease expense was as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Operating lease expense $ 1,332 $ 1,527 $ 2,664 $ 3,060 Amortization of finance lease assets 29 29 57 57 Total lease expense $ 1,361 $ 1,556 $ 2,721 $ 3,117 Leases with an initial term of 12 months or less (“short-term leases”) are not recorded on the balance sheet and are recognized on a straight-line basis over the lease term. Other information related to leases was as follows (dollars in thousands): As of September 30, 2023 March 31, 2023 Supplemental cash flow information related to leases was as follows: Operating leases: Operating lease right-of-use-assets $ 16,906 $ 19,078 Operating lease liabilities, non-current $ 13,950 $ 16,380 Operating lease liabilities, current portion 4,575 4,427 Total operating lease liabilities $ 18,525 $ 20,807 Finance leases: Property, plant and equipment, at cost $ 569 $ 569 Accumulated depreciation (228) (171) Property, plant and equipment, net $ 341 $ 398 Finance lease obligations, non-current $ 225 $ 282 Finance lease obligations, current portion 123 122 Total finance lease liabilities $ 348 $ 404 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flow from operating leases $ 2,984 $ 6,226 Finance cash flows from finance leases 60 119 Additional lease information: ROU assets obtained in exchange for operating lease obligations $ — $ 100 ROU assets obtained in exchange for finance lease obligations — — Reductions to ROU assets resulting from reductions to operating lease obligations 506 1,175 Weighted Average Remaining Lease Term: Operating leases 4.6 years 5.0 years Finance leases 3.0 years 3.5 years Weighted Average Discount Rate: Operating leases 5.06% 5.05% Finance leases 2.08% 2.08% We determined the discount rate for leases using a portfolio approach to determine an incremental borrowing rate to calculate the right-of-use assets and lease liabilities. Maturities of lease liabilities under non-cancellable leases were as follows (in thousands): As of September 30, 2023 Operating leases Finance leases Remainder of fiscal 2024 $ 2,597 $ 60 2025 5,644 120 2026 4,520 120 2027 2,361 59 Thereafter 5,797 — Total undiscounted lease payments 20,919 359 Less imputed interest (2,394) (11) Total lease liabilities $ 18,525 $ 348

Capital Stock

Capital Stock	6 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Capital Stock	CAPITAL STOCK Issuance of Common Stock On June 15, 2023, we entered into a securities purchase agreement (“Securities Purchase Agreement”) with an institutional investor (“Purchaser”). Pursuant to the Securities Purchase Agreement, we agreed to sell in a registered direct offering (“Registered Direct Offering”) 3,525,000 shares (“Shares”) of our common stock, no par value (“Common Stock”), and purchase contracts issued as pre-funded warrants (“Pre-Funded Warrants” and together with the Shares, the "Securities") to purchase up to 573,362 shares of Common Stock, which Pre-Funded Warrants were to be issued to the extent that the Purchaser determined, in its sole discretion, that such Purchaser would beneficially own in excess of 4.99% (or at the Purchaser’s election, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities. The Pre-Funded Warrants had an exercise price of $0.0001 per share, were immediately exercisable and could be exercised at any time after their original issuance date until such Pre-Funded Warrants were exercised in full. Each Share was sold at an offering price of $1.22 and each Pre-Funded Warrant was sold at an offering price of $1.2199 (equal to the purchase price per Share minus the exercise price of the Pre-Funded Warrant). On July 28, 2023, all 573,362 Pre-Funded warrants were exercised, resulting in the issuance of 573,362 shares of Common Stock. Pursuant to the Securities Purchase Agreement, in a concurrent private placement (together with the Registered Direct Offering, the "Offerings"), we also issued to the Purchaser unregistered warrants (“Common Warrants”) to purchase up to 4,098,362 shares of our common stock. Each Common Warrant has an exercise price of $1.35 per share, is exercisable at any time beginning six months following their original issuance date and will expire five and a half years from the original issuance date. As of September 30, 2023, the Common Warrants had not been exercised. In the event of any Fundamental Transaction (as such term is defined in the Securities Purchase Agreement), including any merger or consolidation, sale of substantially all of our assets, tender or exchange offer for 50% or more of our outstanding common stock, reclassification, reorganization or recapitalization of our shares of common stock, or purchase of 50% or more of our outstanding shares of common stock, then upon any subsequent exercise of a Common Warrant, the holder thereof will have the right to receive as alternative consideration, for each share of common stock that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, the number of shares of common stock of the successor or acquiring corporation of our company, if it is the surviving corporation, and any additional consideration receivable upon or as a result of such transaction by a holder of the number of shares of common stock for which the Common Warrant is exercisable immediately prior to such event. Notwithstanding the foregoing, in the event of a Fundamental Transaction, the holders of the Common Warrants have the right to require us or a successor entity to redeem the Common Warrants for cash in the amount of the Black Scholes Value (as such term is defined in the Securities Purchase Agreement) of the unexercised portion of the Common Warrants concurrently with or within 30 days following the consummation of such Fundamental Transaction. We account for our Common Warrants in accordance with the guidance contained in ASC 815-40, Derivatives and Hedging - Contracts on an Entity’s Own Equity, and determined that the Common Warrants do not meet the criteria for equity treatment thereunder. As such, each Common Warrant must be recorded as a liability and is subject to re- measurement at each balance sheet date. Refer to Note 5 - Fair Value Measurements for further details. Changes in fair value are recognized in Other, net in our Condensed Consolidated Statements of Operations. The following table presents the change in the fair value of Common Warrants for the periods indicated below (in thousands): Total Liability balance as of March 31, 2023 $ — Additions of common warrant liability 2,994 Liability balance as of June 30, 2023 2,994 Change in fair value of common warrant liability (1,376) Liability balance as of September 30, 2023 $ 1,618 Roth Capital Partners, LLC (the “Placement Agent”) acted as the exclusive placement agent for the Offerings, pursuant to a Placement Agency Agreement, dated June 15, 2023 (the “Placement Agreement”). Pursuant to the Placement Agreement, we agreed to pay the Placement Agent a cash placement fee equal to 7.0% of the aggregate gross proceeds raised in the Offerings from sales arranged for by the Placement Agent. Subject to certain conditions, we also have agreed to reimburse all reasonable travel and other out-of-pocket expenses of the Placement Agent in connection with the Offerings, including but not limited to legal fees, up to a maximum of $75,000. The Placement Agreement contains customary representations, warranties and agreements by us and customary conditions to closing. We agreed to indemnify the Placement Agent against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”), and liabilities arising from breaches of representations and warranties contained in the Placement Agreement, or to contribute to payments that the Placement Agent may be required to make in respect of those liabilities. We received net proceeds of $4.6 million from the Offerings, net of offering expenses paid to the Placement Agent totaling $0.4 million, which proceeds will be used for general corporate purposes. The closing of the Offerings took place on June 20, 2023. The Securities were offered and sold pursuant to our shelf registration statement on Form S-3 (File No. 333-249979) initially filed with the Securities and Exchange Commission (the “Commission”) on November 9, 2020 and declared effective on October 28, 2021. A prospectus supplement relating to the Registered Direct Offering was filed with the Commission on June 15, 2023. None of the Common Warrants or the shares of Common Stock issuable upon the exercise of the Common Warrants are registered under the Securities Act. The Common Warrants and the shares of Common Stock issuable upon exercise thereof will be issued in reliance on the exemptions from registration provided by Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder for transactions not involving a public offering.

Accrued Liabilities

Accrued Liabilities	6 Months Ended
	Sep. 30, 2023
Payables and Accruals [Abstract]
Accrued Liabilities	ACCRUED LIABILITIES Accrued liabilities consisted of the following (in thousands): As of September 30, 2023 March 31, 2023 Payroll and related liabilities $ 3,517 $ 5,220 Deferred revenue 3,008 5,075 Reserves (1) 1,578 1,200 Accrued Tariffs 1,320 1,167 Other 2,435 2,913 Total accrued liabilities $ 11,858 $ 15,575 (1) Reserves primarily consists of inventory, sales return, sales tax and product liability reserves.

Product Warranties

Product Warranties	6 Months Ended
	Sep. 30, 2023
Product Warranties Disclosures [Abstract]
Product Warranties	PRODUCT WARRANTIES Our products carry defined warranties for defects in materials or workmanship which, according to their terms, generally obligate us to pay the costs of supplying and shipping replacement parts to customers and, in certain instances, pay for labor and other costs to service products. Outstanding product warranty periods range from thirty days to, in limited circumstances, the lifetime of certain product components. We record a liability at the time of sale for the estimated costs of fulfilling future warranty claims. If necessary, we adjust the liability for specific warranty-related matters when they become known and are reasonably estimable. Estimated warranty expense is included in cost of sales, based on historical warranty claim experience and available product quality data. Warranty expense is affected by the performance of new products, significant manufacturing or design defects not discovered until after the product is delivered to the customer, product failure rates, and higher or lower than expected repair costs. If warranty expense differs from previous estimates, or if circumstances change such that the assumptions inherent in previous estimates are no longer valid, the amount of product warranty obligations is adjusted accordingly. Changes in our product warranty obligations were as follows (in thousands): Six-Months Ended September 30, 2023 2022 Balance, beginning of period $ 3,267 $ 6,216 Accruals 2,749 1,882 Payments (2,597) (3,748) Balance, end of period $ 3,419 $ 4,350

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	6 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Accumulated Other Comprehensive Loss	ACCUMULATED OTHER COMPREHENSIVE LOSS The following tables set forth the changes in accumulated other comprehensive loss, net of tax (in thousands): Foreign Currency Translation Adjustments Accumulated Other Comprehensive Loss Balance, March 31, 2023 $ (1,478) $ (1,478) Current period other comprehensive loss before reclassifications (238) (238) Balance, September 30, 2023 $ (1,716) $ (1,716) Foreign Currency Translation Adjustments Accumulated Other Comprehensive Loss Balance, June 30, 2023 $ (1,300) $ (1,300) Current period other comprehensive loss before reclassifications (416) (416) Balance, September 30, 2023 $ (1,716) $ (1,716) Foreign Currency Translation Adjustments Accumulated Other Comprehensive Loss Balance, March 31, 2022 $ (527) $ (527) Current period other comprehensive loss before reclassifications (2,080) (2,080) Balance, September 30, 2022 $ (2,607) $ (2,607)

Loss Per Share

Loss Per Share	6 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
LOSS PER SHARE	LOSS PER SHARE Basic per share amounts were computed using the weighted average number of common shares outstanding. Diluted per share amounts were calculated using the number of basic weighted average shares outstanding increased by dilutive potential common shares related to stock-based awards, as determined by the treasury stock method. Basic income per share amounts were computed using the weighted average number of common shares outstanding. Diluted income per share amounts were calculated using the number of basic weighted average shares outstanding increased by dilutive potential common shares related to stock-based awards, as determined by the treasury stock method. The weighted average numbers of shares outstanding used to compute (loss) income per share were as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Shares used to calculate basic income per share 36,008 31,585 34,192 31,496 Dilutive effect of outstanding stock options, performance stock units and restricted stock units — — — — Shares used to calculate diluted income per share 36,008 31,585 34,192 31,496 Potentially Dilutive Shares The weighted average number of potentially dilutive shares outstanding listed in the table below were excluded from the computation of diluted per share amounts since we had a loss from continuing operations in both periods, as such, the exercise or conversion of any potentially dilutive shares would increase the number of shares in the denominator and result in a lower loss per diluted share. The weighted average number of potentially dilutive shares outstanding were as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Performance stock units 11 — 4 — Restricted stock units — 136 23 241 Stock options — 51 — 107 Total potentially dilutive shares excluded due to net loss 11 187 27 348 Anti-Dilutive Shares The weighted average numbers of shares outstanding listed in the table below were anti-dilutive and excluded from the computation of diluted loss per share. In the case of restricted stock units, this is because unrecognized compensation expense exceeds the current value of the awards (i.e., grant date market value was higher than current average market price). In the case of stock options, this is because the average market price did not exceed the exercise price. These shares may be anti-dilutive potential common shares in the future (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Stock options 2,700 1,696 2,255 1,473 RSUs 1,475 174 1,173 88 Total anti-dilutive shares excluded 4,175 1,870 3,428 1,561

Segment and Enterprise-wide Inf

Segment and Enterprise-wide Information	6 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Segment and Enterprise-wide Information	SEGMENT AND ENTERPRISE-WIDE INFORMATION We have two operating segments, Direct and Retail. There were no changes in our operating segments during the six-months ended September 30, 2023. We evaluate performance of the operating segments using several factors, of which the primary financial measures are net sales and reportable segment contribution. Contribution is the measure of profit or loss, defined as net sales less product costs and directly attributable expenses. Directly attributable expenses include selling and marketing expenses, general and administrative expenses, and research and development expenses that are directly related to segment operations. Segment assets are those directly assigned to an operating segment's operations, primarily accounts receivable, inventories, goodwill and other intangible assets. Unallocated assets primarily include cash, cash equivalents and restricted cash, derivative securities, shared information technology infrastructure, distribution centers, corporate headquarters, prepaids and other current assets, deferred income tax assets and other assets. Capital expenditures directly attributable to the Direct and Retail segments were not significant in any period. Following is summary information by reportable segment (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Net sales: Direct $ 20,737 $ 24,480 $ 42,582 $ 50,957 Retail 27,780 39,905 47,257 67,348 Royalty 142 1,073 570 1,970 Consolidated net sales $ 48,659 $ 65,458 $ 90,409 $ 120,275 Contribution: Direct $ (7,668) $ (7,887) $ (12,376) $ (17,780) Retail 3,663 966 4,045 (4,442) Royalty 142 1,073 570 1,970 Consolidated contribution $ (3,863) $ (5,848) $ (7,761) $ (20,252) Reconciliation of consolidated contribution to loss from continuing operations: Consolidated contribution $ (3,863) $ (5,848) $ (7,761) $ (20,252) Amounts not directly related to segments: Operating expenses (1) (7,345) (8,493) (13,980) (45,274) Other expense, net (883) (816) 5,231 (1,704) Income tax expense (452) (156) (957) (8,252) Loss from continuing operations $ (12,543) $ (15,313) $ (17,467) $ (75,482) (1) Included in unallocated Operating expenses for the six months ended September 30, 2022 is $25.4 million of Goodwill and intangible impairment charge related to the Direct segment and $1.6 million of intangible impairment charge related to the Retail segment that is not included in the contribution performance measured by the chief operating decision maker. As of September 30, 2023 March 31, 2023 Assets: Direct $ 59,084 $ 50,493 Retail 59,999 58,214 Unallocated corporate 48,595 54,825 Total assets $ 167,678 $ 163,532 The following customer accounted for 10% or more of total net sales as follows: Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Amazon.com 21.0% 33.7% 16.4% 31.7%

Borrowings

Borrowings	6 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Borrowings	BORROWINGS Amendment to Existing Term Loan Credit Agreement On July 28, 2023, we entered into an amendment (the “Term Loan Amendment”) to our existing SLR Term Loan with Crystal Financial LLC, d/b/a SLR Credit Solutions ("SLR") dated as of November 30, 2022 (as amended, the "SLR Term Loan"). The Term Loan Amendment provides us with an increased borrowing advance rate for certain eligible accounts owed to us by Amazon.com, Inc. and its affiliates, and allows for certain compliance reports to be delivered to SLR under the SLR Term Loan on a monthly (rather than weekly) basis as long as specified conditions are satisfied. Amendment to Existing ABL Credit Agreement On July 28, 2023, we entered into an amendment (the “ABL Amendment”) to our existing Credit Agreement with Wells Fargo Bank, National Association ("Wells Fargo") dated as of January 31, 2020 (as amended, the "ABL Credit Facility"). The ABL Amendment provides us with an increased borrowing advance rate for certain eligible accounts owed to us by Amazon.com, Inc. and its affiliates and allows for certain compliance reports to be delivered on a monthly (rather than weekly) basis as long as specified conditions are satisfied. In addition, the ABL Amendment reduces the maximum revolving loan commitment amount under the ABL Credit Facility from $60.0 million to $40.0 million. In connection with the amendment of the SLR Term Loan and ABL Credit Facility, we recorded a total loss of $0.3 million, as a component of Other, net in our Condensed Consolidated Statements of Operations. As of September 30, 2023, outstanding principal and accrued and unpaid interest totaled $17.2 million, with $17.2 million and $0.0 million under our SLR Term Loan and ABL Credit Facility, respectively. As of September 30, 2023, we were in compliance with the financial covenants contained in the agreements governing both the SLR Term Loan and ABL Credit Facility, and $29.0 million was available for borrowing under ABL Credit Facility. As of September 30, 2023, our interest rate was 10.41% for the ABL Credit Facility and 13.92% for the SLR Term Loan. Interest on the ABL Credit Facility accrues at the Secured Overnight Financing Rate ("SOFR") plus a margin of 5.00% to 5.50% (based on average quarterly availability) and interest on the SLR Term Loan accrues at SOFR plus a margin of 7.75% to 8.25% (based on fixed charge coverage ratio). The balance sheet classification of the borrowings under the loan facilities has been determined in accordance with ASC 470, Debt .

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES Operating leases We lease property and equipment under non-cancellable operating leases which, in the aggregate, extend through 2029. Many of these leases contain renewal options and provide for rent escalations and payment of real estate taxes, maintenance, insurance and certain other operating expenses of the properties. For additional information related to leases, see Note 11 Leases . Guarantees, Commitments and Off-Balance Sheet Arrangements As of September 30, 2023, we had standby letters of credit of $2.1 million. We have long lead times for inventory purchases and, therefore, must secure factory capacity from our vendors in advance. As of September 30, 2023, we had approximately $20.7 million, compared to $12.1 million as of March 31, 2023, in non-cancellable market-based purchase obligations, primarily to secure additional factory capacity for inventory purchases in the next twelve months. Purchase obligations can vary from quarter-to-quarter and versus the same period in prior years due to a number of factors, including the amount of products that are shipped directly to Retail customer warehouses versus through BowFlex warehouses. In the ordinary course of business, we enter into agreements that require us to indemnify counterparties against third-party claims. These may include: agreements with vendors and suppliers, under which we may indemnify them against claims arising from use of their products or services; agreements with customers, under which we may indemnify them against claims arising from their use or sale of our products; real estate and equipment leases, under which we may indemnify lessors against third-party claims relating to the use of their property; agreements with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions. The nature and terms of these indemnification obligations vary from contract to contract, and generally a maximum obligation is not stated within the agreements. We hold insurance policies that mitigate potential losses arising from certain types of indemnification obligations. Management does not deem these obligations to be significant to our financial position, results of operations or cash flows, and therefore, no related liabilities were recorded as of September 30, 2023. Legal Matters From time to time, in the ordinary course of business, we may be involved in various claims, lawsuits and other proceedings. These legal and tax proceedings involve uncertainty as to the eventual outcomes and losses which may be realized when one or more future events occur or fail to occur.

General Information (Policies)

General Information (Policies)	6 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Consolidation	Intercompany transactions and balances have been eliminated in consolidation.
Basis of Presentation	The accompanying condensed consolidated financial statements have not been audited. We have condensed or omitted certain information and footnote disclosures normally included in financial statements presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes the disclosures contained herein are adequate to make the information presented not misleading. However, these condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2023 (the “2023 Form 10-K”) and for the 10-Q report for the period ended June 30, 2023.The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Uncertainties regarding such estimates and assumptions are inherent in the preparation of financial statements and actual results could differ from those estimates. Further information regarding significant estimates can be found in our 2023 Form 10-K.
New Accounting Pronouncements	Recent Accounting Pronouncements Recently Adopted Pronouncements ASU 2016-13 In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 requires companies to measure credit losses utilizing a methodology that reflects expected credit losses and requires a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. In May 2019, the FASB issued ASU 2019-05, which provides entities to have certain instruments with an option to irrevocably elect the fair value option. In November 2019, the FASB issued ASU 2019-11, which provides clarification and addresses specific issues about certain aspects of ASU 2016-13. In March 2020, the FASB issued ASC 2020-03, which provides an update to clarify or address specific issues. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those years. We adopted ASU 2016-13 on April 1, 2023 and it had no material impact on our financial position, results of operations or cash flows. ASU 2020-06 In August 2020, the FASB issued ASU No. 2020-06, "Debt—Debt with Conversion and Other Options (Subtopic 470-20)" and "Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity," which address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. ASU No. 2020-06 will become effective for us on January 1, 2024. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. FASB specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. We early adopted ASU No. 2020-06 on April 1, 2023 and it had no material impact on our financial position, results of operations or cash flows.

Restructuring and Exit Charges

Restructuring and Exit Charges (Tables)	6 Months Ended
	Sep. 30, 2023
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Reserve by Type of Cost	The following table summarizes restructuring reserve activity (in thousands): Employee Severance and Benefits Third Party Costs Total Accrued liability as of March 31, 2023 $ 1,110 $ 123 $ 1,233 Charges / Accruals — 1,763 1,763 Payments (753) (1,129) (1,882) Accrued liability as of September 30, 2023 $ 357 $ 757 $ 1,114

Revenues (Tables)

Revenues (Tables)	6 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Our revenues from contracts with customers disaggregated by revenue source, excluding sales-based taxes, were as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Product sales $ 44,424 $ 60,107 $ 81,196 $ 109,703 Extended warranties and services 776 938 1,526 1,980 Royalty income 143 1,072 570 1,950 Other (1) 3,316 3,341 7,117 6,642 Net sales $ 48,659 $ 65,458 $ 90,409 $ 120,275 (1) Other revenue is primarily subscription revenue and freight and delivery. Subscriptions Sales of our subscriptions are deemed to be one performance obligation and we recognize revenue from these arrangements ratably over the subscription term as the performance obligation is satisfied. Revenue generated from subscriptions is recorded in our Direct segment. We also offer free trials of subscriptions that are bundled with product offerings (e.g., subscription for premium content). For these types of transactions that involve multiple performance obligations, the transaction price requires allocations to the distinct performance obligation because the free trial provides a material right. The transaction price is then allocated to each performance obligation based on stand-alone selling price. We determine stand-alone selling price based on prices charged to customers. Breakage is factored into the determination of the stand-alone selling price of a subscription. Breakage or activation rate is defined as a percentage of those purchasers that never activate a free-trial offering. Our revenues disaggregated by geographic region, based on ship-to address, were as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 United States $ 38,787 $ 53,440 $ 71,007 $ 99,521 Canada 4,918 8,388 9,366 14,195 Europe, the Middle East and Africa 4,308 2,340 8,664 4,179 All other 646 1,290 1,372 2,380 Net sales $ 48,659 $ 65,458 $ 90,409 $ 120,275
Contract with Customer, Asset and Liability	Significant changes in contract liabilities balances, including revenue recognized in the reporting period that was included in opening contract liabilities, are shown below (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Balance, beginning of period $ 4,432 $ 6,582 $ 5,075 $ 6,285 Cash changes (239) (973) 148 576 Deferred Revenue 551 1,238 1,529 2,220 Revenue recognition (1,736) (2,654) (3,744) (4,888) Balance, end of period $ 3,008 $ 4,193 $ 3,008 $ 4,193

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Assets Measured at Fair Value on a Recurring Basis	Liabilities measured at fair value on a recurring basis were as follows (in thousands): September 30, 2023 Level 1 Level 2 Level 3 Total Liabilities: Common Warrants $ — $ — $ 1,618 $ 1,618 Derivatives Foreign currency forward contracts — 20 — 20 Total liabilities measured at fair value $ — $ 20 $ 1,618 $ 1,638 March 31, 2023 Level 1 Level 2 Level 3 Total Liabilities: Derivatives Foreign currency forward contracts $ — $ 141 $ — $ 141 Total liabilities measured at fair value $ — $ 141 $ — $ 141
Fair Value Measurement Inputs and Valuation Techniques	The key inputs into the Black Scholes pricing model were as follows: September 30, 2023 Stock Price $0.85 Exercise Price $1.35 Expected Life 5.22 Expected Volatility 61.66% Expected Dividend Yield —% Risk Free Rate 4.55%

Derivatives (Tables)

Derivatives (Tables)	6 Months Ended
	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The fair value of our derivative instruments was included in our Condensed Consolidated Balance Sheets as follows (in thousands): Balance Sheet Classification As of September 30, 2023 March 31, 2023 Derivative instruments not designated as cash flow hedges: Foreign currency forward contracts Accrued liabilities $ 20 $ 141
Derivative Instruments, Gain (Loss)	The effect of derivative instruments on our Condensed Consolidated Statements of Operations was as follows (in thousands): Statement of Operations Classification Three-Months ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Derivative instruments not designated as cash flow hedges: Income (loss) recognized in earnings Other, net $ 158 $ (685) $ 158 $ (589) Income tax expense (benefit) Income tax expense (benefit) 39 (170) 39 (146)

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Sep. 30, 2023
Inventory Disclosure [Abstract]
Schedule of Inventories, Net of Valuation Allowances	Our inventories consisted of the following (in thousands): As of September 30, 2023 March 31, 2023 Finished goods $ 62,260 $ 42,463 Parts and components 3,817 4,136 Total inventories $ 66,077 $ 46,599

Property, Plant, and Equipment

Property, Plant, and Equipment (Tables)	6 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant and equipment consisted of the following (in thousands): Estimated As of September 30, 2023 March 31, 2023 Automobiles 5 $ 23 $ 23 Leasehold improvements 4 to 20 3,446 3,426 Computer software and equipment 2 to 7 57,211 57,223 Machinery and equipment 3 to 5 15,188 14,953 Furniture and fixtures 5 to 20 2,033 2,034 Work in progress (1) N/A 5,604 4,061 Total cost 83,505 81,720 Accumulated depreciation (55,153) (48,931) Total property, plant and equipment, net $ 28,352 $ 32,789 (1) Work in progress includes information technology assets and production tooling.
Schedule Of Depreciation Expense	Depreciation expense was as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Depreciation expense $ 3,091 $ 2,464 $ 6,225 $ 4,755

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	6 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	Other intangible assets consisted of the following (in thousands): Estimated As of September 30, 2023 March 31, 2023 Indefinite-lived trademarks N/A $ 2,900 $ 6,597 Patents 7 to 24 1,043 1,043 3,943 7,640 Accumulated amortization - definite-lived intangible assets (884) (853) Other intangible assets, net $ 3,059 $ 6,787
Schedule of Indefinite-Lived Intangible Assets	Other intangible assets consisted of the following (in thousands): Estimated As of September 30, 2023 March 31, 2023 Indefinite-lived trademarks N/A $ 2,900 $ 6,597 Patents 7 to 24 1,043 1,043 3,943 7,640 Accumulated amortization - definite-lived intangible assets (884) (853) Other intangible assets, net $ 3,059 $ 6,787
Amortization Expense	Amortization expense was as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Amortization expense $ 15 $ 16 $ 31 $ 31
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	Future amortization of definite-lived intangible assets is as follows (in thousands): Remainder of fiscal 2024 $ 30 2025 61 2026 47 2027 3 2028 3 Thereafter 15 $ 159

Leases (Tables)

Leases (Tables)	6 Months Ended
	Sep. 30, 2023
Leases [Abstract]
Lease, Cost	Lease expense was as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Operating lease expense $ 1,332 $ 1,527 $ 2,664 $ 3,060 Amortization of finance lease assets 29 29 57 57 Total lease expense $ 1,361 $ 1,556 $ 2,721 $ 3,117
Lessee, Supplemental Cash Flows Information	Other information related to leases was as follows (dollars in thousands): As of September 30, 2023 March 31, 2023 Supplemental cash flow information related to leases was as follows: Operating leases: Operating lease right-of-use-assets $ 16,906 $ 19,078 Operating lease liabilities, non-current $ 13,950 $ 16,380 Operating lease liabilities, current portion 4,575 4,427 Total operating lease liabilities $ 18,525 $ 20,807 Finance leases: Property, plant and equipment, at cost $ 569 $ 569 Accumulated depreciation (228) (171) Property, plant and equipment, net $ 341 $ 398 Finance lease obligations, non-current $ 225 $ 282 Finance lease obligations, current portion 123 122 Total finance lease liabilities $ 348 $ 404 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flow from operating leases $ 2,984 $ 6,226 Finance cash flows from finance leases 60 119 Additional lease information: ROU assets obtained in exchange for operating lease obligations $ — $ 100 ROU assets obtained in exchange for finance lease obligations — — Reductions to ROU assets resulting from reductions to operating lease obligations 506 1,175 Weighted Average Remaining Lease Term: Operating leases 4.6 years 5.0 years Finance leases 3.0 years 3.5 years Weighted Average Discount Rate: Operating leases 5.06% 5.05% Finance leases 2.08% 2.08%
Lessee, Operating Lease, Liability, Maturity	Maturities of lease liabilities under non-cancellable leases were as follows (in thousands): As of September 30, 2023 Operating leases Finance leases Remainder of fiscal 2024 $ 2,597 $ 60 2025 5,644 120 2026 4,520 120 2027 2,361 59 Thereafter 5,797 — Total undiscounted lease payments 20,919 359 Less imputed interest (2,394) (11) Total lease liabilities $ 18,525 $ 348

Capital Stock (Tables)

Capital Stock (Tables)	6 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following table presents the change in the fair value of Common Warrants for the periods indicated below (in thousands): Total Liability balance as of March 31, 2023 $ — Additions of common warrant liability 2,994 Liability balance as of June 30, 2023 2,994 Change in fair value of common warrant liability (1,376) Liability balance as of September 30, 2023 $ 1,618

Accrued Liabilities (Tables)

Accrued Liabilities (Tables)	6 Months Ended
	Sep. 30, 2023
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities	Accrued liabilities consisted of the following (in thousands): As of September 30, 2023 March 31, 2023 Payroll and related liabilities $ 3,517 $ 5,220 Deferred revenue 3,008 5,075 Reserves (1) 1,578 1,200 Accrued Tariffs 1,320 1,167 Other 2,435 2,913 Total accrued liabilities $ 11,858 $ 15,575 (1) Reserves primarily consists of inventory, sales return, sales tax and product liability reserves.

Product Warranties (Tables)

Product Warranties (Tables)	6 Months Ended
	Sep. 30, 2023
Product Warranties Disclosures [Abstract]
Schedule of Product Warranty Liability	Changes in our product warranty obligations were as follows (in thousands): Six-Months Ended September 30, 2023 2022 Balance, beginning of period $ 3,267 $ 6,216 Accruals 2,749 1,882 Payments (2,597) (3,748) Balance, end of period $ 3,419 $ 4,350

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	6 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The following tables set forth the changes in accumulated other comprehensive loss, net of tax (in thousands): Foreign Currency Translation Adjustments Accumulated Other Comprehensive Loss Balance, March 31, 2023 $ (1,478) $ (1,478) Current period other comprehensive loss before reclassifications (238) (238) Balance, September 30, 2023 $ (1,716) $ (1,716) Foreign Currency Translation Adjustments Accumulated Other Comprehensive Loss Balance, June 30, 2023 $ (1,300) $ (1,300) Current period other comprehensive loss before reclassifications (416) (416) Balance, September 30, 2023 $ (1,716) $ (1,716) Foreign Currency Translation Adjustments Accumulated Other Comprehensive Loss Balance, March 31, 2022 $ (527) $ (527) Current period other comprehensive loss before reclassifications (2,080) (2,080) Balance, September 30, 2022 $ (2,607) $ (2,607)

Loss Per Share (Tables)

Loss Per Share (Tables)	6 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The weighted average numbers of shares outstanding used to compute (loss) income per share were as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Shares used to calculate basic income per share 36,008 31,585 34,192 31,496 Dilutive effect of outstanding stock options, performance stock units and restricted stock units — — — — Shares used to calculate diluted income per share 36,008 31,585 34,192 31,496
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The weighted average number of potentially dilutive shares outstanding were as follows (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Performance stock units 11 — 4 — Restricted stock units — 136 23 241 Stock options — 51 — 107 Total potentially dilutive shares excluded due to net loss 11 187 27 348 Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Stock options 2,700 1,696 2,255 1,473 RSUs 1,475 174 1,173 88 Total anti-dilutive shares excluded 4,175 1,870 3,428 1,561

Segment and Enterprise-wide I_2

Segment and Enterprise-wide Information (Tables)	6 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Summary Information by Reportable Segments	Following is summary information by reportable segment (in thousands): Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Net sales: Direct $ 20,737 $ 24,480 $ 42,582 $ 50,957 Retail 27,780 39,905 47,257 67,348 Royalty 142 1,073 570 1,970 Consolidated net sales $ 48,659 $ 65,458 $ 90,409 $ 120,275 Contribution: Direct $ (7,668) $ (7,887) $ (12,376) $ (17,780) Retail 3,663 966 4,045 (4,442) Royalty 142 1,073 570 1,970 Consolidated contribution $ (3,863) $ (5,848) $ (7,761) $ (20,252) Reconciliation of consolidated contribution to loss from continuing operations: Consolidated contribution $ (3,863) $ (5,848) $ (7,761) $ (20,252) Amounts not directly related to segments: Operating expenses (1) (7,345) (8,493) (13,980) (45,274) Other expense, net (883) (816) 5,231 (1,704) Income tax expense (452) (156) (957) (8,252) Loss from continuing operations $ (12,543) $ (15,313) $ (17,467) $ (75,482) (1) Included in unallocated Operating expenses for the six months ended September 30, 2022 is $25.4 million of Goodwill and intangible impairment charge related to the Direct segment and $1.6 million of intangible impairment charge related to the Retail segment that is not included in the contribution performance measured by the chief operating decision maker. As of September 30, 2023 March 31, 2023 Assets: Direct $ 59,084 $ 50,493 Retail 59,999 58,214 Unallocated corporate 48,595 54,825 Total assets $ 167,678 $ 163,532
Schedules of Concentration of Risk, by Risk Factor	The following customer accounted for 10% or more of total net sales as follows: Three-Months Ended September 30, Six-Months Ended September 30, 2023 2022 2023 2022 Amazon.com 21.0% 33.7% 16.4% 31.7%

General Information (Details)

General Information (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Restricted cash	$ 2,158	$ 950	$ 946

Restructuring and Exit Charge_2

Restructuring and Exit Charges (Details) $ in Thousands	6 Months Ended
	Sep. 30, 2023 USD ($)
Restructuring Reserve [Roll Forward]
Accrued liability as of March 31, 2023	$ 1,233
Charges / Accruals	1,763
Payments	(1,882)
Accrued liability as of September 30, 2023	1,114
Employee Severance and Benefits
Restructuring Reserve [Roll Forward]
Accrued liability as of March 31, 2023	1,110
Charges / Accruals	0
Payments	(753)
Accrued liability as of September 30, 2023	357
Third Party Costs
Restructuring Reserve [Roll Forward]
Accrued liability as of March 31, 2023	123
Charges / Accruals	1,763
Payments	(1,129)
Accrued liability as of September 30, 2023	$ 757

Revenues (Details)

Revenues (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Change In Contract With Customer Liability [Roll Forward]
Balance, beginning of period	$ 4,432	$ 6,285	$ 5,075	$ 6,582
Cash changes	(239)	(973)	148	576
Contract With Customer, Liability, Increase From Deferred Revenue	551	1,238	1,529	2,220
Revenue recognition	(1,736)	(2,654)	(3,744)	(4,888)
Balance, end of period	3,008	4,193	3,008	4,193
Net sales	48,659	65,458	90,409	120,275
United States
Change In Contract With Customer Liability [Roll Forward]
Net sales	38,787	53,440	71,007	99,521
Canada
Change In Contract With Customer Liability [Roll Forward]
Net sales	4,918	8,388	9,366	14,195
Europe, the Middle East and Africa
Change In Contract With Customer Liability [Roll Forward]
Net sales	4,308	2,340	8,664	4,179
All other
Change In Contract With Customer Liability [Roll Forward]
Net sales	646	1,290	1,372	2,380
Product sales
Change In Contract With Customer Liability [Roll Forward]
Net sales	44,424	60,107	81,196	109,703
Extended warranties and services
Change In Contract With Customer Liability [Roll Forward]
Net sales	776	938	1,526	1,980
Other
Change In Contract With Customer Liability [Roll Forward]
Net sales	3,316	3,341	7,117	6,642
Royalty Income
Change In Contract With Customer Liability [Roll Forward]
Net sales	$ 143	$ 1,072	$ 570	$ 1,950

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
Derivatives
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	$ 1,618	$ 2,994	$ 0
Fair Value, Measurements, Recurring
Derivatives
Total liabilities measured at fair value	1,638		141
Fair Value, Measurements, Recurring | Level 1
Derivatives
Total liabilities measured at fair value	0		0
Fair Value, Measurements, Recurring | Level 2
Derivatives
Total liabilities measured at fair value	20		141
Fair Value, Measurements, Recurring | Level 3
Derivatives
Total liabilities measured at fair value	1,618		0
Foreign currency forward contracts | Fair Value, Measurements, Recurring
Liabilities:
Common Warrants	1,618
Derivatives
Foreign currency forward contracts	20		141
Foreign currency forward contracts | Fair Value, Measurements, Recurring | Level 1
Liabilities:
Common Warrants	0
Derivatives
Foreign currency forward contracts	0		0
Foreign currency forward contracts | Fair Value, Measurements, Recurring | Level 2
Liabilities:
Common Warrants	0
Derivatives
Foreign currency forward contracts	20		141
Foreign currency forward contracts | Fair Value, Measurements, Recurring | Level 3
Liabilities:
Common Warrants	1,618
Derivatives
Foreign currency forward contracts	$ 0		$ 0

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Unobservable Inputs (Details)	Sep. 30, 2023
Stock Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Outstanding warrant, measurement input	0.85
Exercise Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Outstanding warrant, measurement input	1.35
Expected Life
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Outstanding warrant, measurement input	5.22
Expected Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Outstanding warrant, measurement input	0.6166
Expected Dividend Yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Outstanding warrant, measurement input	0
Risk Free Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Outstanding warrant, measurement input	0.0455

Derivatives - Narrative (Detail

Derivatives - Narrative (Details) - Foreign currency forward contracts $ in Millions	6 Months Ended
	Sep. 30, 2023 USD ($)
Derivative [Line Items]
Derivative, notional amount	$ 2.3
Derivative, term of contract	62 days

Derivatives - Fair value of der

Derivatives - Fair value of derivative instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Mar. 31, 2023
Foreign currency forward contracts | Derivative instruments not designated as cash flow hedges: | Accrued liabilities
Derivatives, Fair Value [Line Items]
Fair value of liability derivatives	$ 20	$ 141

Derivatives - Effect On Condens

Derivatives - Effect On Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other, net	Other, net	Other, net	Other, net
Not Designated as Hedging Instruments
Derivative Instruments, Gain (Loss) [Line Items]
Income (loss) recognized in earnings	$ 158	$ (685)	$ 158	$ (589)
Not Designated as Hedging Instruments | Income tax expense
Derivative Instruments, Gain (Loss) [Line Items]
Income tax benefit	$ 39	$ (170)	$ 39	$ (146)

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Mar. 31, 2023
Inventory Disclosure [Abstract]
Finished goods	$ 62,260	$ 42,463
Parts and components	3,817	4,136
Total inventories	$ 66,077	$ 46,599

Property, Plant and Equipment (

Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Mar. 31, 2023
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 83,505	$ 81,720
Accumulated depreciation	(55,153)	(48,931)
Total property, plant and equipment, net	28,352	32,789
Automobiles
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 23	23
Automobiles | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	5 years
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 3,446	3,426
Leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	4 years
Leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	20 years
Computer software and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 57,211	57,223
Computer software and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	2 years
Computer software and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	7 years
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 15,188	14,953
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	3 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	5 years
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 2,033	2,034
Furniture and fixtures | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	5 years
Furniture and fixtures | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in years)	20 years
Work in Progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 5,604	$ 4,061

Property, Plant and Equipment -

Property, Plant and Equipment - Depreciation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Depreciation	$ 3,091	$ 2,464	$ 6,225	$ 4,755

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Sep. 30, 2022	Mar. 31, 2023
Goodwill [Line Items]
Indefinite-lived trademarks	$ 2,900	$ 2,900		$ 6,597
Total other intangible assets, gross	3,943	3,943		7,640
Accumulated amortization - definite-lived intangible assets	(884)	(884)		(853)
Other intangible assets, net	3,059	3,059		6,787
Proceeds from sale of indefinite-lived intellectual property	10,500	10,500	$ 0
Carrying value of intangible assets sold	3,700	3,700
Patents
Goodwill [Line Items]
Finite-lived intangible assets, gross	$ 1,043	$ 1,043		$ 1,043
Patents | Minimum
Goodwill [Line Items]
Estimated Useful Life (in years)	7 years	7 years
Patents | Maximum
Goodwill [Line Items]
Estimated Useful Life (in years)	24 years	24 years

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Patent amortization (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 15	$ 16	$ 31	$ 31

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Future intangible amortization (Details) $ in Thousands	Sep. 30, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of fiscal 2024	$ 30
2025	61
2026	47
2027	3
2028	3
Thereafter	15
Finite-Lived Intangible Assets, Net	$ 159

The Sale of Shares In Equity _2

The Sale of Shares In Equity Investments (Details) - USD ($) $ in Thousands		3 Months Ended	6 Months Ended
	May 01, 2023	Sep. 30, 2023	Sep. 30, 2023	Sep. 30, 2022
Equity Method Investments and Joint Ventures [Abstract]
Proceeds from Sale of Equity Method Investments	$ 2,300		$ 2,350	$ 0
Equity Method Investments	0
Equity Method Investment, Aggregate Cost	$ 100
Equity Method Investment, Realized Gain (Loss) on Disposal		$ 2,200

Leases - Additional information

Leases - Additional information (Details)	Sep. 30, 2023 term
Leases [Abstract]
Operating lease, term of contract	7 years
Operating lease, number of renewal terms	1
Operating lease, renewal term	5 years

Leases - Lease Cost (Details)

Leases - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Leases [Abstract]
Operating lease expense	$ 1,332	$ 1,527	$ 2,664	$ 3,060
Amortization of finance lease assets	29	29	57	57
Total lease expense	$ 1,361	$ 1,556	$ 2,721	$ 3,117

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow (Details) - USD ($) $ in Thousands	6 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Mar. 31, 2022	Mar. 31, 2023
Leases [Abstract]
Operating lease right-of-use-assets	$ 16,906			$ 19,078
Operating lease liabilities, non-current	13,950			16,380
Operating lease liabilities, current portion	4,575			4,427
Total lease liabilities	18,525			20,807
Property, plant and equipment, at cost	569			569
Accumulated depreciation	(228)			(171)
Property, plant and equipment, net	341			398
Finance lease obligations, non-current	225			282
Finance lease obligations, current portion	123			122
Total finance lease liabilities	348			$ 404
Operating cash flow from operating leases	2,984		$ 6,226
Finance cash flows from finance leases	60	$ 60	119
ROU assets obtained in exchange for operating lease obligations	0		100
ROU assets obtained in exchange for finance lease obligations	0		0
Reductions to ROU assets resulting from reductions to operating lease obligations	$ 506		$ 1,175
Operating leases, Weighted Average Remaining Lease Term	4 years 7 months 6 days			5 years
Finance leases, Weighted Average Remaining Lease Term	3 years			3 years 6 months
Operating leases, Weighted Average Discount Rate, Percent	5.06%			5.05%
Finance leases, Weighted Average Discount Rate, Percent	2.08%			2.08%

Leases - Maturity (Details)

Leases - Maturity (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Mar. 31, 2023
Operating leases
2024	$ 2,597
2025	5,644
2026	4,520
2027	2,361
Thereafter	5,797
Total undiscounted lease payments	20,919
Less imputed interest	(2,394)
Total lease liabilities	18,525	$ 20,807
Finance leases
2024	60
2025	120
2026	120
2027	59
Thereafter	0
Total undiscounted lease payments	359
Less imputed interest	(11)
Total finance lease liabilities	$ 348	$ 404

Capital Stock (Details)

Capital Stock (Details) - USD ($) $ / shares in Units, $ in Thousands	Jul. 28, 2023	Jun. 15, 2023
Class of Stock [Line Items]
Issuance of common stock and pre-funded warrants, net (in shares)	573,362
Maximum cost reimbursement		$ 75
Private Placement One
Class of Stock [Line Items]
Number of shares issued in transaction (in shares)		3,525,000
Exercise price of warrants (in dollars per share)		$ 0.0001
Offer price per warrant for exchange (in dollars per share)		1.22
Offering price for pre-funded warrant (in dollars per share)		$ 1.2199
Number of shares of common stock called by warrants	573,362	573,362
Private Placement One | Minimum
Class of Stock [Line Items]
Excess of ownership percentage		4.99%
Private Placement One | Maximum
Class of Stock [Line Items]
Excess of ownership percentage		9.99%
Private Placement Two
Class of Stock [Line Items]
Exercise price of warrants (in dollars per share)		$ 1.35
Number of shares of common stock called by warrants		4,098,362
Stock issuance fee percentage		7%
Consideration received on issuance		$ 4,600
Amount of stock issuance costs		$ 400

Capital Stock - Warrant Liabili

Capital Stock - Warrant Liability Rollforward (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Jun. 30, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning liability balance	$ 2,994	$ 0
Additions of common warrant liability		2,994
Change in fair value of common warrant liability	(1,376)
Ending liability balance	$ 1,618	$ 2,994

Accrued Liabilities (Details)

Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Mar. 31, 2023
Payables and Accruals [Abstract]
Payroll and related liabilities	$ 3,517	$ 5,220
Deferred revenue	3,008	5,075
Reserves	1,578	1,200
Accrued Tariffs, Current	1,320	1,167
Other	2,435	2,913
Total accrued liabilities	$ 11,858	$ 15,575

Product Warranties (Details)

Product Warranties (Details) - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Movement in Product Warranty Liability [Roll Forward]
Balance, beginning of period	$ 3,267	$ 6,216
Accruals	2,749	1,882
Payments	(2,597)	(3,748)
Balance, end of period	$ 3,419	$ 4,350
Minimum
Product Liability Contingency [Line Items]
Product warranty period	30 days

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 59,071	$ 104,847	$ 61,300	$ 164,049
Current period other comprehensive income (loss) before reclassifications	(416)	(1,221)	(238)	(2,080)
Ending balance	47,123	91,619	47,123	91,619
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(1,300)	(1,386)	(1,478)	(527)
Current period other comprehensive income (loss) before reclassifications	(416)	(1,221)	(238)	(2,080)
Ending balance	(1,716)	(2,607)	(1,716)	(2,607)
Accumulated Other Comprehensive Loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(1,300)	(1,386)	(1,478)	(527)
Ending balance	$ (1,716)	$ (2,607)	$ (1,716)	$ (2,607)

Loss Per Share - Weighted Avera

Loss Per Share - Weighted Average Number of Shares (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Earnings Per Share [Abstract]
Basic (in shares)	36,008	31,585	34,192	31,496
Dilutive effect of outstanding stock options, performance stock units and restricted stock units (in shares)	0	0	0	0
Shares used to calculate diluted income per share (in shares)	36,008	31,585	34,192	31,496
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of diluted income per share (in shares)	11	187	27	348
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of diluted income per share (in shares)	0	51	0	107
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of diluted income per share (in shares)	0	136	23	241

Loss Per Share - Schedule of Po

Loss Per Share - Schedule of Potentially Dilutive Shares (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of diluted income per share (in shares)	11	187	27	348
Performance stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of diluted income per share (in shares)	11	0	4	0
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of diluted income per share (in shares)	0	136	23	241
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of diluted income per share (in shares)	0	51	0	107

Loss Per Share - Anti-dilutive

Loss Per Share - Anti-dilutive Common Shares (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of diluted income per share (in shares)	4,175	1,870	3,428	1,561
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of diluted income per share (in shares)	2,700	1,696	2,255	1,473
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of diluted income per share (in shares)	1,475	174	1,173	88

Segment and Enterprise-wide I_3

Segment and Enterprise-wide Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) segment	Sep. 30, 2022 USD ($)	Mar. 31, 2023 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | segment			2
Net sales	$ 48,659	$ 65,458	$ 90,409	$ 120,275
Contribution	(3,863)	(5,848)	(7,761)	(20,252)
Reconciliation of consolidated contribution to income (loss) from continuing operations:
Operating expenses	(21,162)	(25,800)	(40,345)	(83,942)
Income tax expense	(452)	(156)	(957)	(8,251)
Loss from continuing operations	(12,543)	(15,313)	(17,467)	(75,482)
Assets	167,678		167,678		$ 163,532
Direct
Reconciliation of consolidated contribution to income (loss) from continuing operations:
Asset impairment charge	25,400
Retail
Reconciliation of consolidated contribution to income (loss) from continuing operations:
Asset impairment charge	1,600
Unallocated corporate
Reconciliation of consolidated contribution to income (loss) from continuing operations:
Assets	48,595		48,595		54,825
Operating Segments
Segment Reporting Information [Line Items]
Net sales	48,659	65,458	90,409	120,275
Contribution	(3,863)	(5,848)	(7,761)	(20,252)
Operating Segments | Royalty
Segment Reporting Information [Line Items]
Net sales	142	1,073	570	1,970
Unallocated royalty income, net	142	1,073	570	1,970
Operating Segments | Direct
Segment Reporting Information [Line Items]
Net sales	20,737	24,480	42,582	50,957
Contribution	(7,668)	(7,887)	(12,376)	(17,780)
Reconciliation of consolidated contribution to income (loss) from continuing operations:
Assets	59,084		59,084		50,493
Operating Segments | Retail
Segment Reporting Information [Line Items]
Net sales	27,780	39,905	47,257	67,348
Contribution	3,663	966	4,045	(4,442)
Reconciliation of consolidated contribution to income (loss) from continuing operations:
Assets	59,999		59,999		$ 58,214
Corporate, Non-Segment
Reconciliation of consolidated contribution to income (loss) from continuing operations:
Operating expenses	(7,345)	(8,493)	(13,980)	(45,274)
Other expense, net	(883)	(816)	5,231	(1,704)
Income tax expense	$ (452)	$ (156)	$ (957)	$ (8,252)

Segment and Enterprise-wide I_4

Segment and Enterprise-wide Information - Concentration (Details)	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Amazon.com | Sales Revenue, Net | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	21%	33.70%	16.40%	31.70%

Borrowings (Loan Agreement) (De

Borrowings (Loan Agreement) (Details) - USD ($)			6 Months Ended
	Nov. 30, 2022	Nov. 29, 2022	Sep. 30, 2023	Sep. 30, 2022	Jul. 28, 2023	Jul. 27, 2023
Line of Credit Facility [Line Items]
Loss on debt extinguishment			$ 352,000	$ 0
Credit Facility
Line of Credit Facility [Line Items]
Loss on debt extinguishment			300,000
Line of Credit | SLR Credit Agreement
Line of Credit Facility [Line Items]
Maximum revolving secured credit line					$ 40,000,000	$ 60,000,000
Line of Credit | Wells Fargo Bank
Line of Credit Facility [Line Items]
Amount outstanding			17,200,000
Line of Credit | Wells Fargo Bank | ABL Revolving Credit Facility
Line of Credit Facility [Line Items]
Available for borrowing under line of credit			$ 29,000,000
Borrowing rate under agreement, at period end			10.41%
Line of Credit | Wells Fargo Bank | Term Loan
Line of Credit Facility [Line Items]
Borrowing rate under agreement, at period end			13.92%
Line of Credit | Wells Fargo Bank | Term Loan | SLR Credit Agreement
Line of Credit Facility [Line Items]
Amount outstanding			$ 17,200,000
Line of Credit | Wells Fargo Bank | Term Loan | WF Credit Facility
Line of Credit Facility [Line Items]
Amount outstanding			$ 0
Minimum | Line of Credit | WF Credit Facility | Variable Rate Component One
Line of Credit Facility [Line Items]
Basis spread on variable rate		5%
Minimum | Line of Credit | Secured Debt | Secured Overnight Financing Rate (SOFR) | SLR Credit Agreement | Variable Rate Component One
Line of Credit Facility [Line Items]
Basis spread on variable rate	7.75%
Maximum | Line of Credit | WF Credit Facility | Variable Rate Component One
Line of Credit Facility [Line Items]
Basis spread on variable rate		5.50%
Maximum | Line of Credit | Secured Debt | Secured Overnight Financing Rate (SOFR) | SLR Credit Agreement | Variable Rate Component One
Line of Credit Facility [Line Items]
Basis spread on variable rate	8.25%

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	Sep. 30, 2023	Mar. 31, 2023
Purchase Commitment, Excluding Long-term Commitment [Line Items]
Standby letters of credit outstanding	$ 2.1
Inventories
Purchase Commitment, Excluding Long-term Commitment [Line Items]
Non-cancelable market-based purchase obligation	$ 20.7	$ 12.1